These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16501760)

  • 1. Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment.
    Mayrink W; Botelho AC; Magalhães PA; Batista SM; Lima Ade O; Genaro O; Costa CA; Melo MN; Michalick MS; Williams P; Dias M; Caiaffa WT; Nascimento Ed; Machado-Coelho GL
    Rev Soc Bras Med Trop; 2006; 39(1):14-21. PubMed ID: 16501760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemotherapy in American cutaneous leishmaniasis: immunological aspects before and after treatment.
    Toledo VP; Mayrink W; Gollob KJ; Oliveira MA; Costa CA; Genaro O; Pinto JA; Afonso LC
    Mem Inst Oswaldo Cruz; 2001 Jan; 96(1):89-98. PubMed ID: 11285479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients.
    Cabrera M; Blackwell JM; Castes M; Trujillo D; Convit J; Shaw MA
    Parasite Immunol; 2000 Feb; 22(2):73-9. PubMed ID: 10652119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed Leishmania (Leishmania) amazonensis vaccine plus antimonial.
    Machado-Pinto J; Pinto J; da Costa CA; Genaro O; Marques MJ; Modabber F; Mayrink W
    Int J Dermatol; 2002 Feb; 41(2):73-8. PubMed ID: 11982640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.
    López L; Robayo M; Vargas M; Vélez ID
    Trials; 2012 May; 13():58. PubMed ID: 22594858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative antimonial schedule to be used in cutaneous leishmaniasis when high doses of antimony are undesirable.
    de Oliveira-Neto MP; Mattos Mda S
    Rev Soc Bras Med Trop; 2006; 39(4):323-6. PubMed ID: 17119744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American cutaneous leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-methilglucamine antimoniate plus pentoxifylline.
    Báfica A; Oliveira F; Freitas LA; Nascimento EG; Barral A
    Int J Dermatol; 2003 Mar; 42(3):203-7. PubMed ID: 12653916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment against American cutaneous leishmaniasis by intralesional infiltration of a generic antimonial compound-lidocaine combination. A follow up study.
    Añez N; Rojas A; Scorza-Dagert JV; Morales C
    Acta Trop; 2018 Sep; 185():261-266. PubMed ID: 29883574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis.
    Convit J; Castellanos PL; Rondon A; Pinardi ME; Ulrich M; Castes M; Bloom B; Garcia L
    Lancet; 1987 Feb; 1(8530):401-5. PubMed ID: 2880213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy as a treatment of American cutaneous leishmaniasis: preliminary studies in Brazil.
    Mayrink W; Magalhaes PA; Michalick MS; da Costa CA; Lima Ade O; Melo MN; Toledo VP; Nascimento E; Dias M; Genaro O
    Parassitologia; 1992 Dec; 34(1-3):159-65. PubMed ID: 1339971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional treatment of cutaneous leishmaniasis with meglumine antimoniate.
    Aste N; Pau M; Ferreli C; Biggio P
    Br J Dermatol; 1998 Feb; 138(2):370-1. PubMed ID: 9602904
    [No Abstract]   [Full Text] [Related]  

  • 13. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate.
    Momeni AZ; Reiszadae MR; Aminjavaheri M
    Int J Dermatol; 2002 Jul; 41(7):441-3. PubMed ID: 12121563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly vs. fortnightly intralesional meglumine antimoniate in cutaneous leishmaniasis.
    Mujtaba G; Khalid M
    Int J Dermatol; 1999 Aug; 38(8):607-9. PubMed ID: 10487452
    [No Abstract]   [Full Text] [Related]  

  • 16. Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial.
    Firooz A; Khamesipour A; Ghoorchi MH; Nassiri-Kashani M; Eskandari SE; Khatami A; Hooshmand B; Gorouhi F; Rashighi-Firoozabadi M; Dowlati Y
    Arch Dermatol; 2006 Dec; 142(12):1575-9. PubMed ID: 17178983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A; Amini Harandi A
    Ann Trop Med Parasitol; 2003 Jul; 97(5):493-8. PubMed ID: 12930612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis.
    Nascimento E; Fernandes DF; Vieira EP; Campos-Neto A; Ashman JA; Alves FP; Coler RN; Bogatzki LY; Kahn SJ; Beckmann AM; Pine SO; Cowgill KD; Reed SG; Piazza FM
    Vaccine; 2010 Sep; 28(40):6581-7. PubMed ID: 20688040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ; Aminjavaheri M
    Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T; Lehn N; Landthaler M; Stolz W
    Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.